Glucocorticoids delay RAF-induced senescence promoted by EGR1.

Journal of cell science (2019-08-03)
Cyril Carvalho, Valentin L'Hôte, Régis Courbeyrette, Gueorgui Kratassiouk, Guillaume Pinna, Jean-Christophe Cintrat, Cyril Denby-Wilkes, Céline Derbois, Robert Olaso, Jean-François Deleuze, Carl Mann, Jean-Yves Thuret

Expression of hyperactive RAF kinases, such as the oncogenic B-RAF-V600E mutant, in normal human cells triggers a proliferative arrest that blocks tumor formation. We discovered that glucocorticoids delayed the entry into senescence induced by B-RAF-V600E in human fibroblasts, and allowed senescence bypass when the cells were regularly passaged, but that they did not allow proliferation of cells that were already senescent. Transcriptome and siRNA analyses revealed that the EGR1 gene is one target of glucocorticoid action. Transcription of the EGR1 gene is activated by the RAF-MEK-ERK MAPK pathway and acts as a sensor of hyper-mitogenic pathway activity. The EGR1 transcription factor regulates the expression of p15 and p21 (encoded by CDKN2B and CDKN1A, respectively) that are redundantly required for the proliferative arrest of BJ fibroblasts upon expression of B-RAF-V600E. Our results highlight the need to evaluate the action of glucocorticoid on cancer progression in melanoma, thyroid and colon carcinoma in which B-RAF-V600E is a frequent oncogene, and cancers in which evasion from senescence has been shown.

Product Number
Product Description

MEM Non-essential Amino Acid Solution (100×), without L-glutamine, liquid, sterile-filtered, BioReagent, suitable for cell culture
Sodium pyruvate solution, 100 mM, sterile-filtered, BioReagent, suitable for cell culture
4-Hydroxytamoxifen, ≥70% Z isomer (remainder primarily E-isomer)
Doxycycline hydrochloride
2-Phenylindole, technical grade, 95%